19 May 2026
Jones Day welcomes life sciences IP strategist and biologics patent prosecution partner Shovon Ashraf to Boston
"Jones Day hires Dr. Shovon Ashraf as Partner in its Intellectual Property Practice in Boston to strengthen life sciences IP work, focusing on biologics and patent prosecution."
Dr. Ashraf is a life sciences IP attorney with nearly 20 years of experience advising biotechnology and pharmaceutical companies and academic institutions across biopharma. His practice focuses on biologics, including antibodies, antibody-drug conjugates, peptides, oligonucleotides and other gene and cell therapies, and encompasses patent prosecution, portfolio strategy, freedom-to-operate analysis, licensing and IP due diligence.
Prior to joining Jones Day, Dr. Ashraf served as Vice President, Intellectual Property—Biologics at Neurocrine Biosciences, Inc., where he built and led an in-house IP team of patent attorneys and agents and developed offensive and defensive IP strategies across a broad range of biological modalities. While at Neurocrine, he played a pivotal role in negotiating several multi-billion dollar cross-border IP licensing and collaboration agreements. He has also worked in private practice.
Dr. Ashraf earned his law degree from The George Washington University Law School, a Ph.D. in Molecular Cell Biology from the University of Massachusetts Medical School and an M.S. in Epidemiology from the Harvard School of Public Health, and completed post-doctoral research in neuroscience at Harvard University.